Should anthracyclines and dexrazoxane be used for children with cancer?

Elvira C. van Dalen; Henk van den Berg; Martine F. Raphaël; Huib N. Caron; Leontien C. Kremer

doi:10.1016/S1470-2045(10)70301-6

Should anthracyclines and dexrazoxane be used for children with cancer?

Elvira C. van Dalen, Henk van den Berg, Martine F. Raphaël, Huib N. Caron, Leontien C. Kremer

Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review

15 Citaten (Scopus)

Originele taal-2	Engels
Pagina's (van-tot)	12-13
Aantal pagina's	2
Tijdschrift	The Lancet Oncology
Volume	12
Nummer van het tijdschrift	1
DOI's	https://doi.org/10.1016/S1470-2045(10)70301-6
Status	Gepubliceerd - jan. 2011
Extern gepubliceerd	Ja

Toegang tot document

10.1016/S1470-2045(10)70301-6

Citeer dit

@article{f276b58afb764d2697dc76e3dba6a666,

title = "Should anthracyclines and dexrazoxane be used for children with cancer?",

author = "{van Dalen}, {Elvira C.} and {van den Berg}, Henk and Rapha{\"e}l, {Martine F.} and Caron, {Huib N.} and Kremer, {Leontien C.}",

note = "Funding Information: The Cochrane Childhood Cancer Group is funded by Stichting Kinderen Kankervrij (KIKA), the Netherlands. The authors declared no conflicts of interest.",

year = "2011",

month = jan,

doi = "10.1016/S1470-2045(10)70301-6",

language = "English",

volume = "12",

pages = "12--13",

journal = "The Lancet Oncology",

issn = "1470-2045",